Clinical Trial Update: Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy plus cetuximab in patients with peritoneal carcinomatosis from colorectal cancer undergoing surgery; the trial was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Institut Bergonié | Conditions: Colorectal Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-01-26